Synta Pharma Home



PIPELINE

Synta has a diverse pipeline of novel, small molecule drug candidates targeting cancer and inflammatory diseases, two of the largest therapeutic markets in the world.

Each program represents an independent drug category with a distinct chemical family and mechanism of action. All of our clinical candidates were developed internally and Synta currently fully owns all rights in all geographic markets and in all indications.

ABOUT |  PIPELINE | CLINICAL TRIALS |  TECHNOLOGY |  INVESTORS  |  CAREERS

Copyright © 2008Synta Pharmaceuticals Corp. All rights reserved. Terms of Use